A placebo-controlled, parallel group multicenter phase III trial of Topically-applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction (ED)
Phase of Trial: Phase III
Latest Information Update: 26 Apr 2018
At a glance
- Drugs Nitroglycerin (Primary)
- Indications Erectile dysfunction
- Focus Registrational; Therapeutic Use
- Sponsors Futura Medical
- 26 Apr 2018 According to a Futura Medical media release, the company expects to dose last patient by end of June 2019 and to report efficacy results by December 2019.
- 26 Apr 2018 According to a Futura Medical media release, the company is targeting for first patient to be dosed by the end of September 2018.
- 14 Mar 2018 According to a Futura Medical media release, first patient is expected to enroll early in Q32018.